SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)

Market Cap	3.44B
Revenue (ttm)	1.29B
Net Income (ttm)	299.66M
Shares Out	44.59M
EPS (ttm)	6.70
PE Ratio	11.50
Forward PE	n/a
Dividend	5.30 (6.87%)
Ex-Dividend Date	Jul 21, 2025

Volume	8,330
Average Volume	30,623
Open	77.90
Previous Close	77.00
Day's Range	77.10 - 78.00
52-Week Range	72.00 - 110.00
Beta	-0.09
RSI	63.07
Earnings Date	Nov 5, 2025

About SYN-TECH Chem. & Pharm.

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, antiulcerative, antihypertensive, α- blocker, vasodilator, bronchodilator, anxiolytic, tranquilizer, local anest...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1982
• Employees: 227
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1777

Financial Performance

In 2024, SYN-TECH Chem. & Pharm.'s revenue was 1.26 billion, an increase of 12.83% compared to the previous year's 1.11 billion. Earnings were 393.28 million, an increase of 56.68%.